BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 25483567)

  • 1. Abnormal levels of heterogeneous nuclear ribonucleoprotein A2B1 (hnRNPA2B1) in tumour tissue and blood samples from patients diagnosed with lung cancer.
    Dowling P; Pollard D; Larkin A; Henry M; Meleady P; Gately K; O'Byrne K; Barr MP; Lynch V; Ballot J; Crown J; Moriarty M; O'Brien E; Morgan R; Clynes M
    Mol Biosyst; 2015 Mar; 11(3):743-52. PubMed ID: 25483567
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fyn requires HnRNPA2B1 and Sam68 to synergistically regulate apoptosis in pancreatic cancer.
    Chen ZY; Cai L; Zhu J; Chen M; Chen J; Li ZH; Liu XD; Wang SG; Bie P; Jiang P; Dong JH; Li XW
    Carcinogenesis; 2011 Oct; 32(10):1419-26. PubMed ID: 21642356
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of melanoma antigens using a Serological Proteome Approach (SERPA).
    Suzuki A; Iizuka A; Komiyama M; Takikawa M; Kume A; Tai S; Ohshita C; Kurusu A; Nakamura Y; Yamamoto A; Yamazaki N; Yoshikawa S; Kiyohara Y; Akiyama Y
    Cancer Genomics Proteomics; 2010; 7(1):17-23. PubMed ID: 20181627
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Identification and clinical evaluation of lung cancer serum biomarker L-lactate dehydrogenase B].
    Chen Y; Zhang H; Xu AJ; Liu JF; Li N; Wu SS; Huang LY; He DC; Xiao XY
    Zhonghua Jie He He Hu Xi Za Zhi; 2007 Aug; 30(8):577-81. PubMed ID: 17988549
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heterogeneous nuclear ribonucleoprotein A1 is identified as a potential biomarker for colorectal cancer based on differential proteomics technology.
    Ma YL; Peng JY; Zhang P; Huang L; Liu WJ; Shen TY; Chen HQ; Zhou YK; Zhang M; Chu ZX; Qin HL
    J Proteome Res; 2009 Oct; 8(10):4525-35. PubMed ID: 19715280
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined detection of CEA, CK-19 and c-met mRNAs in peripheral blood: a highly sensitive panel for potential molecular diagnosis of non-small cell lung cancer.
    Sheu CC; Chang MY; Chang HC; Tsai JR; Lin SR; Chang SJ; Hwang JJ; Huang MS; Chong IW
    Oncology; 2006; 70(3):203-11. PubMed ID: 16809939
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative proteomic analysis of lung cancer cell line and lung fibroblast cell line.
    Rubporn A; Srisomsap C; Subhasitanont P; Chokchaichamnankit D; Chiablaem K; Svasti J; Sangvanich P
    Cancer Genomics Proteomics; 2009; 6(4):229-37. PubMed ID: 19657000
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heterogeneous nuclear ribonucleoprotein A2/B1 in association with hTERT is a potential biomarker for hepatocellular carcinoma.
    Mizuno H; Honda M; Shirasaki T; Yamashita T; Yamashita T; Mizukoshi E; Kaneko S
    Liver Int; 2012 Aug; 32(7):1146-55. PubMed ID: 22372738
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Loss of hnRNPA2B1 inhibits malignant capability and promotes apoptosis via down-regulating Lin28B expression in ovarian cancer.
    Yang Y; Wei Q; Tang Y; Yuanyuan Wang ; Luo Q; Zhao H; He M; Wang H; Zeng Q; Lu W; Xu J; Liu T; Yi P
    Cancer Lett; 2020 Apr; 475():43-52. PubMed ID: 32006618
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of plasma hnRNP B1 mRNA, a new cancer biomarker, in lung cancer patients by quantitative real-time polymerase chain reaction.
    Sueoka E; Sueoka N; Iwanaga K; Sato A; Suga K; Hayashi S; Nagasawa K; Nakachi K
    Lung Cancer; 2005 Apr; 48(1):77-83. PubMed ID: 15777973
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The HNRNPA2B1-MST1R-Akt axis contributes to epithelial-to-mesenchymal transition in head and neck cancer.
    Gupta A; Yadav S; Pt A; Mishra J; Samaiya A; Panday RK; Shukla S
    Lab Invest; 2020 Dec; 100(12):1589-1601. PubMed ID: 32669614
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proteomics-based identification of secreted protein dihydrodiol dehydrogenase as a novel serum markers of non-small cell lung cancer.
    Huang LJ; Chen SX; Huang Y; Luo WJ; Jiang HH; Hu QH; Zhang PF; Yi H
    Lung Cancer; 2006 Oct; 54(1):87-94. PubMed ID: 16876904
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overexpression of hnRNPA2/B1 in bronchoscopic specimens: a potential early detection marker in lung cancer.
    Katsimpoula S; Patrinou-Georgoula M; Makrilia N; Dimakou K; Guialis A; Orfanidou D; Syrigos KN
    Anticancer Res; 2009 Apr; 29(4):1373-82. PubMed ID: 19414390
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HNRNPA2B1 Demonstrates Diagnostic and Prognostic Values Based on Pan-Cancer Analyses.
    Chen C; Huang L; Sun Q; Yu Z; Wang X; Bu L
    Comput Math Methods Med; 2022; 2022():9867660. PubMed ID: 35529270
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Role of heterogeneous nuclear ribonucleoprotein A2/B1 protein in the pathogenesis of non-small cell lung cancer].
    Shi Y; Chen Y; Hou YY; Ji CH; Hu Q; Zhou Y; Su JA; Tan YS
    Zhonghua Zhong Liu Za Zhi; 2011 Feb; 33(2):110-4. PubMed ID: 21575478
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevation of serum l-lactate dehydrogenase B correlated with the clinical stage of lung cancer.
    Chen Y; Zhang H; Xu A; Li N; Liu J; Liu C; Lv D; Wu S; Huang L; Yang S; He D; Xiao X
    Lung Cancer; 2006 Oct; 54(1):95-102. PubMed ID: 16890323
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of α1-antitrypsin as a potential prognostic biomarker for advanced nonsmall cell lung cancer treated with epidermal growth factor receptor tyrosine kinase inhibitors by proteomic analysis.
    Zhao W; Yang Z; Liu X; Tian Q; Lv Y; Liang Y; Li C; Gao X; Chen L
    J Int Med Res; 2013 Jun; 41(3):573-83. PubMed ID: 23613495
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined use of oligonucleotide and tissue microarrays identifies cancer/testis antigens as biomarkers in lung carcinoma.
    Sugita M; Geraci M; Gao B; Powell RL; Hirsch FR; Johnson G; Lapadat R; Gabrielson E; Bremnes R; Bunn PA; Franklin WA
    Cancer Res; 2002 Jul; 62(14):3971-9. PubMed ID: 12124329
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Unraveling Molecular Differences of Gastric Cancer by Label-Free Quantitative Proteomics Analysis.
    Dai P; Wang Q; Wang W; Jing R; Wang W; Wang F; Azadzoi KM; Yang JH; Yan Z
    Int J Mol Sci; 2016 Jan; 17(1):. PubMed ID: 26805816
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of serum proteome components associated with progression of non-small cell lung cancer.
    Pietrowska M; Jelonek K; Michalak M; Roś M; Rodziewicz P; Chmielewska K; Polański K; Polańska J; Gdowicz-Kłosok A; Giglok M; Suwiński R; Tarnawski R; Dziadziuszko R; Rzyman W; Widłak P
    Acta Biochim Pol; 2014; 61(2):325-31. PubMed ID: 24872961
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.